
Sign up to save your podcasts
Or
Credits: 0.25 AMA PRA Category 1 Credit™
Overview: While GLP-1 agents are center stage in the medical and lay press, drugs in the class of sodium-glucose cotransporter 2 inhibitors (SGLT2is) are also quite remarkable at improving a variety of health endpoints. This episode provides an overview of studies supporting the use of SGLT2is to improve patient outcomes.
Episode resource links:
Guest: Susan Feeney, DNP, FNP-BC, NP-C
4.5
8383 ratings
Credits: 0.25 AMA PRA Category 1 Credit™
Overview: While GLP-1 agents are center stage in the medical and lay press, drugs in the class of sodium-glucose cotransporter 2 inhibitors (SGLT2is) are also quite remarkable at improving a variety of health endpoints. This episode provides an overview of studies supporting the use of SGLT2is to improve patient outcomes.
Episode resource links:
Guest: Susan Feeney, DNP, FNP-BC, NP-C
494 Listeners
688 Listeners
282 Listeners
278 Listeners
255 Listeners
3,324 Listeners
1,113 Listeners
717 Listeners
193 Listeners
290 Listeners
514 Listeners
249 Listeners
364 Listeners
228 Listeners
315 Listeners